Sort
130,381 grants matching “hiv”
Animal Model for Testing SIV Latency Reversal Strategies
$847,031Cristian Apetrei · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AI
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression
$847,023Mohamed Abdel Mohsen · Wistar Institute · R01 · FY2022 · NS
Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.
$846,976Francis W. Ruscetti · Basic Sciences · Z01 · FY2007 · CA
STRUCTURE OF THE HIV INITIATION COMPLEX
$846,956University Of Alabama At Birmingham · P01 · FY2000 · GM
3BNC117 and 10-1074 to suppress HIV-1 replication and reduce the reservoir
$846,953Marina Caskey · Rockefeller University · U01 · FY2018 · AI
Novel Humanized Mouse Models For Engraftment of Tissue-Specific Human Macrophage Population
$846,948Michael Allen Brehm · Univ Of Massachusetts Med Sch Worcester · R24 · FY2025 · OD
Multi-omics characterization of HIV-associated changes in the gut microbiome and host mucosal immunity
$846,940Douglas Kwon · Massachusetts General Hospital · R01 · FY2021 · DK
Multi-omics characterization of HIV-associated changes in the gut microbiome and host mucosal immunity
$846,940Douglas Kwon · Massachusetts General Hospital · R01 · FY2022 · DK
NKT cells as modulators of AIDS vaccine efficacy
$846,896Amitinder Kaur · Harvard Medical School · R01 · FY2012 · AI
Core G: Clinical Cohort and Comorbidity Research
$846,888Mari M Kitahata · University Of Washington · P30 · FY2022 · AI
Center for Advancing Longtiudinal Drug Abuse Research
$846,776Yih-Ing Hser · University Of California Los Angeles · P30 · FY2014 · DA
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$846,737Pamela J Bjorkman · California Institute Of Technology · P01 · FY2025 · AI
Role of clonal expansion in HIV-1 persistence
$846,629Ya-Chi Ho · Yale University · R01 · FY2025 · AI
Immunophenotyping for precision medicine for cardiovascular disease in people living with HIV
$846,562Robert C Kaplan · Albert Einstein College Of Medicine · R01 · FY2019 · HL
Development of highly neutralizing nanobodies against HIV-1, SARS-CoV-2 and other pathogens
$846,518Rafael C Casellas · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2022 · AR
Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence
$846,498Joshua Tisdell Schiffer · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
HIV THERAPY ADHERENCE AND VIRAL RESISTANCE IN DRUG USERS
$846,495Montefiore Medical Center (Bronx, Ny) · R01 · FY2000 · DA
Rapid Analysis of Single Nucleotide Polymorphism Genotypes in AIDS Cohorts
$846,454Stephen J O'Brien · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Office of the Clinical Director Clinical Services Research
$846,359Maryland Pao · National Institute Of Mental Health · ZIA · FY2021 · MH
An injectable hydrogel platform for sustained release of eCD4-Ig
$846,301Michael R. Farzan · Scripps Florida · R01 · FY2021 · AI
Center for the Dissemination of Ultra-Long-Acting Antiretroviral Release Technology: DART Resource Program
$846,258Alessandro Grattoni · Methodist Hospital Research Institute · R24 · FY2025 · AI
Determinants of HIV-1 innate immune sensing and its role in shaping the lymphoid environment.
$846,223Sunnie Yoh · Scripps Research Institute, The · R01 · FY2025 · AI
Structural Biology Of Virus Assembly
$846,167Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2020 · AR
An Interdisciplinary Approach to HIV and Other Infectious Diseases of Drug Users
$846,122Sherry Deren · New York University · P30 · FY2009 · DA
Adolescent HIV Risk-Social settings &Prevention Issues
$846,094Hunter College · R01 · FY2002 · MH